Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control studyResearch in context
Summary: Background: After primary vaccination schemes with rAd26-rAd5 (Sputnik V), ChAdOx1 nCoV-19, BBIBP-CorV or heterologous combinations, the effectiveness of homologous or heterologous boosters (Sputnik V, ChAdOx, Pfizer-BioNTech, Moderna) against SARS-CoV-2 infections, hospitalisations and dea...
Saved in:
Main Authors: | Soledad González (Author), Santiago Olszevicki (Author), Alejandra Gaiano (Author), Martín Salazar (Author), Lorena Regairaz (Author), Ana Nina Varela Baino (Author), Erika Bartel (Author), Teresa Varela (Author), Veronica V. González Martínez (Author), Santiago Pesci (Author), Lupe Marín (Author), Juan Ignacio Irassar (Author), Leticia Ceriani (Author), Enio Garcia (Author), Nicolás Kreplak (Author), Elisa Estenssoro (Author), Franco Marsico (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study
by: Soledad González, et al.
Published: (2022) -
Synergism therapeutic and immunoregulatory effects of Albendazole + rAd-mIL-28B against Echinococcosis in experiment-infected mice with protoscoleces.
by: Yan Zhang, et al.
Published: (2021) -
Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy
by: Donya Hatami, et al.
Published: (2024) -
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka.
by: Chandima Jeewandara, et al.
Published: (2022) -
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
by: Chandima Jeewandara, et al.
Published: (2022)